Abstract
Depression is a common psychiatric disorder with substantial recurrence risk. Accurate prediction from easily collected data would aid in diagnosis, treatment and prevention. We used machine learning in the Generation Scotland cohort to predict lifetime risk of depression and, among cases, recurrent depression. Rank aggregation was used to combine results across ten different algorithms and identify highly predictive variables. The model containing all but the cardiometabolic predictors had the highest predictive ability on independent data. Rank aggregation produced a reduced set of predictors without decreasing predictive performance (lifetime: 20 out of 154 predictors and Receiver Operating Characteristic area under the curve (AUC)=0·84, recurrent: 10 out of 180 predictors and AUC=0·76). Here we develop a pipeline which leads to a small set of highly predictive variables. This information can be easily collected with a smartphone ‘application’ to help diagnosis and treatment, while longitudinal tracking may help patients in self-management.
Significance Depression is the most common psychiatric disorder and a leading cause of disability worldwide. Patients are often diagnosed and treated by non-specialist clinicians who have limited time available to assess them. We present a novel methodology which allowed us to identify a small set of highly predictive variables for a diagnosis of depression, or recurrent depression in patients. This information can easily be collected using a tablet or smartphone application in the clinic to aid diagnosis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
VEG and KKN were supported by a University of Edinburgh-Medical Research Council (https://mrc.ukri.org/) Confidence in Concept award and by a Wellcome Trust (https://wellcome.ac.uk/)-University of Edinburgh Institutional Strategic Support Fund award (to KKN). KKN, MLB, DUM, FA, PM, DJP were supported by a University of Edinburgh-Medical Research Council (https://mrc.ukri.org/) Confidence in Concept award (to DJP). KKN and JJM were supported by the Rosetrees Trust (http://www.rosetreestrust.co.uk/; M405) and VEG, SER and KKN by a Chancellors Fellowship from the University of Edinburgh. DUM was supported by European Union FP7 (https://ec.europa.eu/research/fp7/index_en.cfm) 316861 MLPM. DJM acknowledges the financial support of NHS Research Scotland (http://www.nhsresearchscotland.org.uk/; NRS), through NHS Lothian. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates (http://www.cso.scot.nhs.uk/) [CZD/16/6] and the Scottish Funding Council (http://www.sfc.ac.uk/) [HR03006]. Genotyping of the GS:SFHS samples was carried out by the Genetics Core Laboratory at the Wellcome Trust Clinical Research Facility, Edinburgh, Scotland and was funded by the Medical Research Council UK (https://mrc.ukri.org/) and the Wellcome Trust (https://wellcome.ac.uk/; Wellcome Trust Strategic Award STratifying Resilience and Depression Longitudinally (STRADL) Reference 104036/Z/14/Z). We are grateful to all the families who took part, the general practitioners and the Scottish School of Primary Care for their help in recruiting them, and the whole Generation Scotland team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Generation Scotland data are available under managed access by submitting a proposal to the Generation Scotland Data Access Committee.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The authors have declared that no conflict of interest exists.
Data Availability
Generation Scotland data are available under managed access by submitting a proposal to the Generation Scotland Data Access Committee.
